Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • cw11
    Member
    • Sep 2011
    • 12

    #1

    Effect of outlier sample on CuffDiff analysis?

    Unless I'm much mistaken, CuffDiff pools reads from all samples within a condition prior to differential expression analysis. Does anyone understand the method by which CuffDiff prevents an outlier (for instance, one sample overexpressing a gene significantly more than the others) from skewing the results? How reliable have other users found this method to be?

    (I did read http://cufflinks.cbcb.umd.edu/howitworks - just having some difficulty understanding it).
  • mehc
    Member
    • Aug 2011
    • 10

    #2
    I would like to know this also. We 'fixed' the cases with DESeq where one replicate had abnormal read counts vs the other replicates and made the genes highly significative (ex 0,0,0,high vs 0,0,0,0). However I'm wondering if there is something similar for cuffdiff, as the top transcript results still contain these cases

    Thanks

    Comment

    • mehc
      Member
      • Aug 2011
      • 10

      #3
      bump, anyone know where else I could ask this? (e-mailed cufflinks, no answer)

      Comment

      • Dameon
        Member
        • Dec 2011
        • 14

        #4
        I believe that Cuffdiff uses LocFit Regression in the case were there are no biological replicates to estimate dispersion with inferences made from a Poisson distribution. I do not believe that Cuffdiff takes any special consideration of outlier samples during this step except to use just those genes that are rank invariant and not differentially expressed across all your samples. In the case of biological replicates, I think Cuffdiff estimates the over-dispersion based on a negative binomial model from within each sample group. Again, I don't think Cuffdiff takes any special consideration of outliers during this step either. Personally, I think if your data contains outliers, you would be better off using something like DESeq or EdgeR where you can build a generalized linear model to account for such outliers or exclude them entirely during your sample QC process (R plots). Lastly, if your dataset does not contain biological replicates, I would hold off on doing any analysis until you do; otherwise, your data would have little value due to low statistical power to make inferences.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        15 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Working...